7/2/2026
In a trial of 218 adults with newly diagnosed relapsing MS, rituximab and Ocrevus had similar brain ...
4/8/2025
In two trials of relapsing MS, tolebrutinib did not reduce flare-ups more than Aubagio. Disability w...
4/8/2025
In a trial of 1,131 people with secondary progressive MS without relapses, fewer taking tolebrutinib...
10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel...
10/6/2026
In children with MS, immune attacks on the brain and spinal cord may go unchecked. See what research...
10/6/2026
Researchers found immune cells that swap surface tags in MS. An MS treatment removed them in the stu...
10/5/2026
A 10-year MS study found that starting ocrelizumab early helped protect movement and reduce relapses...
10/5/2026
Could CAR T-cell therapy help people with MS? Learn what new expert guidance covers, why careful fol...
10/1/2026
A study links a body chemical to MS inflammation and shows that blocking its source eases symptoms i...
9/30/2026
A lab study found engineered immune cells eased skin inflammation in mice, but it did not test peopl...